421
Views
25
CrossRef citations to date
0
Altmetric
Original

Olfaction, psychiatric disorders and autoimmunity: Is there a common genetic association?

, &
Pages 80-88 | Received 28 May 2008, Accepted 23 Jul 2008, Published online: 07 Jul 2009

References

  • Pucak ML, Carroll KA, Kerr DA, Kaplin AI. Neuropsychiatric manifestations of depression in multiple sclerosis: Neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression. Dialogues Clin Neurosci 2007; 9: 139
  • Hawkes C. Olfaction in neurodegenerative disorder. Adv Otorhinolaryngol 2006; 63: 133–151
  • Valtýsdóttir ST, Gudbjörnsson B, Lindqvist U, Hällgren R, Hetta J. Anxiety and depression in patients with primary Sjögren's syndrome. J Rheumatol 2000; 27: 165–169
  • Zorzon M, Ukmar M, Bragadin LM, Zanier F, Antonello RM, Cazzato G, Zivadinov R. Olfactory dysfunction and extent of white matter abnormalities in multiple sclerosis: A clinical and MR study. Mult Scler 2000; 6: 386–390
  • Zivadinov R, Zorzon M, Monti Bragadin L, Pagliaro G, Cazzato G. Olfactory loss in multiple sclerosis. J Neurol Sci 1999; 168(1)27–30
  • Shoenfeld Y. To smell autoimmunity: Anti-P-ribosomal autoantibodies, depression, and the olfactory system. J Autoimmun 2007; 28: 165–169
  • Emmer BJ, van der Grond J, Steup-Beekman GM, Huizinga TW, van Buchem MA. Selective involvement of the amygdala in systemic lupus erythematosus. PLos Med 2006; 3: e499
  • Shoenfeld Y, Gilburd B, Abu-Shakra M, Amital H, Barzilai O, Berkun Y, et al. The mosaic of autoimmunity: Genetic factors involved in autoimmune diseases–2008. Isr Med Assoc J 2008; 10: 3–7
  • Shoenfeld Y, Zandman-Goddard G, Stojanovich L, Cutolo M, Amital H, Levy Y, et al. The mosaic of autoimmunity: Hormonal and environmental factors involved in autoimmune diseases–2008. Isr Med Assoc J 2008; 10: 8–12
  • Shoenfeld Y, Blank M, Abu-Shakra M, Amital H, Barzilai O, Berkun Y, et al. The mosaic of autoimmunity: Prediction, autoantibodies, and therapy in autoimmune diseases–2008. Isr Med Assoc J 2008; 10: 13–19
  • Hermann R, Laine AP, Veijola R, Vahlberg T, Simell S, Lähde J, et al. The effect of HLA class II, insulin and CTLA4 gene regions on the development of humoral beta cell autoimmunity. Diabetologia 2005; 48: 1766–1775
  • Younger RM, Amadou C, Bethel G, Ehlers A, Lindahl KF, Forbes S, et al. Characterization of clustered MHC-linked olfactory receptor-genes in human and mouse. Genome Res 2001; 11: 519–530
  • Song C, Leonard BE. The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev 2005; 29: 627–647
  • Jarosik J, Legutko B, Unsicker K, von Bohlen Und Halbach O. Antidepressant-mediated reversal of abnormal behavior and neurodegeneration in mice following olfactory bulbectomy. Exp Neurol 2007; 204: 20–28
  • Konarski JZ, McIntyre RS, Kennedy SH, Rafi-Tari S, Soczynska JK, Ketter TA. Volumetric neuroimaging investigations in mood disorders: Bipolar disorder versus major depressive disorder. Bipolar Disord 2008; 10: 1–37
  • Drevets WC. Prefrontal cortical-amygdalar metabolism in major depression. Ann N Y Acad Sci 1999; 877: 614–637
  • Wagner G, Koch K, Schachtzabel C, Reichenbach JR, Sauer H, Schlösser Md RG. Enhanced rostral anterior cingulate cortex activation during cognitive control is related to orbitofrontal volume reduction in unipolar depression. J Psychiatry Neurosci 2008; 33: 199–208
  • Drevets WC. Orbitofrontal cortex function and structure in depression. Ann N Y Acad Sci 2007; 1121: 499–527
  • Tonelli LH, Stiller J, Rujescu D, Giegling I, Schneider B, Maurer K, et al. Elevated cytokine expression in the orbitofrontal cortex of victims of suicide. Acta Psychiatr Scand 2008; 117: 198–206
  • Drevets WC. Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog Brain Res 2000; 126: 413–431
  • Hermesh H, Zohar J, Weizman A, Voet H, Gross-Isseroff R. Orbitofrontal cortex dysfunction in obsessive-compulsive disorder? II. Olfactory quality discrimination in obsessive-compulsive disorder. Eur Neuropsychopharmacol 1999; 9: 415–420
  • Mucignat-Caretta C, Bondí M, Caretta A. Time course of alterations after olfactory bulbectomy in mice. Physiol Behav 2006; 89: 637–643
  • Sheline YI, Gado MH, Price JL. Amygdala core nuclei volumes are decreased in recurrent major depression. Neuroreport 1998; 9: 2023–2028
  • Whalen PJ, Shin LM, Somerville LH, McLean AA, Kim H. Functional neuroimaging studies of the amygdala in depression. Semin Clin Neuropsychiatry 2002; 7: 234–242
  • Matthews SC, Strigo IA, Simmons AN, Yang TT, Paulus MP. Decreased functional coupling of the amygdala and supragenual cingulate is related to increased depression in unmedicated individuals with current major depressive disorder. J Affect Disorders 2008, doi:10.1016/j.jad.2008.05.022
  • Müller F, O'Rahilly R. The amygdaloid complex and the medial and lateral ventricular eminences in staged human embryos. J Anat 2006; 208: 547–564
  • Müller F, O'Rahilly R. Olfactory structures in staged human embryos. Cells Tissues Organs 2004; 178: 93–116
  • Tian H, Ma M. Differential development of odorant receptor expression patterns in the olfactory epithelium: A quantitative analysis in the mouse septal organ. Dev Neurobiol 2008; 68: 476–486
  • Tsuboi A, Miyazaki T, Imai T, Sakano H. Olfactory sensory neurons expressing class I odorant receptors converge their axons on an antero-dorsal domain of the olfactory bulb in the mouse. Eur J Neurosci 2006; 23: 1436–1444
  • Tsuboi A, Yoshihara S, Yamazaki N, Kasai H, Asai-Tsuboi H, Komatsu M, et al. Olfactory neurons expressing closely linked and homologous odorant receptor genes tend to project their axons to neighboring glomeruli on the olfactory bulb. J Neurosci 1999; 19: 8409–8418
  • Feldmesser E, Olender T, Khen M, Yanai I, Ophir R, Lancet D. Widespread ectopic expression of olfactory receptor-genes. BMC Genomics 2006; 7: 121
  • Glusman G, Yanai I, Rubin I, Lancet D. The complete human olfactory subgenome. Genome Res 2001; 11: 685–702
  • Fan W, Liu YC, Parimoo S, Weissman SM. Olfactory receptor-like genes are located in the human major histocompatibility complex. Genomics 1995; 27: 119–123
  • Ehlers A, Beck S, Forbes SA, Trowsdale J, Volz A, Younger R, et al. MHC-linked olfactory receptor loci exhibit polymorphism and contribute to extended HLA/OR-haplotypes. Genome Res 2000; 10: 1968–1978
  • Pilpel Y, Lancet D. The variable and conserved interfaces of modeled olfactory receptor proteins. Protein Sci 1999; 8: 969–977
  • Volz A, Ehlers A, Younger R, Forbes S, Trowsdale J, Schnorr D, et al. Complex transcription and splicing of odorant receptor-genes. J Biol Chem 2003; 278: 19691–19701
  • Gaudin JC, Breuils L, Haertlé T. New GPCRs from a human lingual cDNA library. Chem Senses 2001; 26: 1157–1166
  • Feingold EA, Penny LA, Nienhuis AW, Forget BG. An olfactory receptor gene is located in the extended human beta-globin gene cluster and is expressed in erythroid cells. Genomics 1999; 61: 15–23
  • Xu LL, Stackhouse BG, Florence K, Zhang W, Shanmugam N, Sesterhenn IA, et al. PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer. Cancer Res 2000; 60: 6568–6572
  • Itakura S, Ohno K, Ueki T, Sato K, Kanayama N. Expression of Golf in the rat placenta: Possible implication in olfactory receptor transduction. Placenta 2006; 27: 103–108
  • Weber M, Pehl U, Breer H, Strotmann J. Olfactory receptor expressed in ganglia of the autonomic nervous system. J Neurosci Res 2002; 68: 176–184
  • Yuan TT, Toy P, McClary JA, Lin RJ, Miyamoto NG, Kretschmer PJ. Cloning and genetic characterization of an evolutionarily conserved human olfactory receptor that is differentially expressed across species. Gene 2001; 278: 41–51
  • Saito H, Mimmack M, Kishimoto J, Keverne EB, Emson PC. Expression of olfactory receptors, G-proteins and AxCAMs during the development and maturation of olfactory sensory neurons in the mouse. Brain Res Dev Brain Res 1998; 110: 69–81
  • Otaki JM, Yamamoto H, Firestein S. Odorant receptor expression in the mouse cerebral cortex. J Neurobiol 2004; 58: 315–327
  • Zhang X, De la Cruz O, Pinto JM, Nicolae D, Firestein S, Gilad Y. Characterizing the expression of the human olfactory receptor gene family using a novel DNA microarray. Genome Biol 2007; 8: R86
  • Goto T, Salpekar A, Monk M. Expression of a testis-specific member of the olfactory receptor gene family in human primordial germ cells. Mol Hum Reprod 2001; 7: 553–558
  • Wedekind C, Seebeck T, Bettens F, Paepke AJ. MHC-dependent mate preferences in humans. Proc Biol Sci 1995, 260: 245–249
  • Santos PS, Schinemann JA, Gabardo J, Bicalho Mda G. New evidence that the MHC influences odor perception in humans: A study with 58 Southern Brazilian students. Horm Behav 2005; 47: 384–388
  • Eklund AC, Belchak MM, Lapidos K, Raha-Chowdhury R, Ober C. Polymorphisms in the HLA-linked olfactory receptor-genes in the Hutterites. Hum Immunol 2000; 61: 711–717
  • Dreyer WJ. The area code hypothesis revisited: Olfactory receptors and other related transmembrane receptors may function as the last digits in a cell surface code for assembling embryos. Proc Natl Acad Sci USA 1998; 95: 9072–9077
  • Pause BM, Miranda A, Göder R, Aldenhoff JB, Ferstl R. Reduced olfactory performance in patients with major depression. J Psychiatr Res 2001; 35: 271–277
  • Lombion-Pouthier S, Vandel P, Nezelof S, Haffen E, Millot JL. Odor perception in patients with mood disorders. J Affect Disord 2006; 90: 187–191
  • Gross-Isseroff R, Luca-Haimovici K, Sasson Y, Kindler S, Kotler M, Zohar J. Olfactory sensitivity in major depressive disorder and obsessive compulsive disorder. Biol Psychiatry 1994; 35: 798–802
  • Pollatos O, Albrecht J, Kopietz R, Linn J, Schoepf V, Kleemann AM, et al. Reduced olfactory sensitivity in subjects with depressive symptoms. J Affect Disord 2007; 102: 101–108
  • Brewer WJ, Wood SJ, Pantelis C, Berger GE, Copolov DL, McGorry PD. Olfactory sensitivity through the course of psychosis: Relationships to olfactory identification, symptomatology and the schizophrenia odour. Psychiatry Res 2007; 149: 97–104
  • Moberg PJ, Agrin R, Gur RE, Gur RC, Turetsky BI, Doty RL. Olfactory dysfunction in schizophrenia: A qualitative and quantitative review. Neuropsychopharmacology 1999; 21: 325–340
  • Good KP, Whitehorn D, Rui Q, Milliken H, Kopala LC. Olfactory identification deficits in first-episode psychosis may predict patients at risk for persistent negative and disorganized or cognitive symptoms. Am J Psychiatry 2006; 163: 932–933
  • Turetsky BI, Kohler CG, Gur RE, Moberg PJ. Olfactory physiological impairment in first-degree relatives of schizophrenia patients. Schizophr Res 2008; 102: 220–229
  • Kopala LC, Good KP, Morrison K, Bassett AS, Alda M, Honer WG. Impaired olfactory identification in relatives of patients with familial schizophrenia. Am J Psychiatry 2001; 158: 1286–1290
  • Stancer HC, Weitkamp LR, Persad E, Flood C, Jorna T, Guttormsen SA, et al. Confirmation of the relationship of HLA (chromosome 6) genes to depression and manic depression. II. The Ontario follow-up and analysis of 117 kindreds. Ann Hum Genet 1988; 52: 279–298
  • Weitkamp LR, Stancer HC. Analysis of the Toronto-Rochester Depression Study follow-up data confirms an HLA-region gene contribution to susceptibility to affective disorder. Genet Epidemiol 1989; 6: 305–310
  • Strous RD, Shoenfeld Y. Schizophrenia, autoimmunity and immune system dysregulation: A comprehensive model updated and revisited. J Autoimmun 2006; 27: 71–80
  • Eaton WW, Byrne M, Ewald H, Mors O, Chen CY, Agerbo E, et al. Association of schizophrenia and autoimmune diseases: Linkage of Danish national registers. Am J Psychiatry 2006; 163: 521–528
  • Sirota P, Firer M, Schild K, Zurgil N, Barak Y, Elizur A, et al. Increased anti-Sm antibodies in schizophrenic patients and their families. Prog Neuropsychopharmacol Biol Psychiatry 1993; 17: 793–800
  • Na KS, Kim YK. Monocytic,Th1 and th2 cytokine alterations in the pathophysiology of schizophrenia. Neuropsychobiology 2007; 56: 55–63
  • Gorwood P, Pouchot J, Vinceneux P, Puéchal X, Flipo RM, De Bandt M, et al. Rheumatoid arthritis and schizophrenia: A negative association at a dimensional level. Schizophr Res 2004; 66: 21–29
  • Sasaki T, Matsushita M, Nanko S, Fukuda R, Kennedy JL, Tokunaga K. Schizophrenia and the HLA-DRB1 gene in the Japanese population. Am J Psychiatry 1999; 156: 771–773
  • Furuya T, Hakoda M, Ichikawa N, Higami K, Nanke Y, Yago T, et al. Differential association of HLA-DRB1 alleles in Japanese patients with early rheumatoid arthritis in relationship to autoantibodies to cyclic citrullinated peptide. Clin Exp Rheumatol 2007; 25: 219–224
  • Müller N, Schwarz MJ. The immune-mediated alteration of serotonin and glutamate: Towards an integrated view of depression. Mol Psychiatry 2007; 12: 988–1000
  • Myint AM, Leonard BE, Steinbusch HW, Kim YK. Th1, Th2, and Th3 cytokine alterations in major depression. J Affect Disord 2005; 88: 167–173
  • Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 201–217
  • Barnetche T, Constantin A, Cantagrel A, Cambon-Thomsen A, Gourraud PA. New classification of HLA-DRB1 alleles in rheumatoid arthritis susceptibility: A combined analysis of worldwide samples. Arthritis Res Ther 2008; 10: R26
  • Gottenberg JE, Busson M, Loiseau P, Cohen-Solal J, Lepage V, Charron D, et al. In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheum 2003; 48: 2240–2245
  • Bakhtadze E, Borg H, Stenström G, Fernlund P, Arnqvist HJ, Ekbom-Schnell A, et al. HLA-DQB1 genotypes, islet antibodies and beta cell function in the classification of recent-onset diabetes among young adults in the nationwide Diabetes Incidence Study in Sweden. Diabetologia 2006; 49: 1785–1794
  • Tollefsen S, Arentz-Hansen H, Fleckenstein B, Molberg O, Ráki M, Kwok WW, et al. HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease. J Clin Invest 2006; 116: 2226–2236
  • Arnett FC, Reveille JD, Moutsopoulos HM, Georgescu L, Elkon KB. Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations. Arthritis Rheum 1996; 39: 1833–1839
  • Teh LS, Doherty DG, Williams BD. HLA-DRB genes and antiribosomal P antibodies in systemic lupus erythematosus. Br J Rheumatol 1994; 33: 1125–1126
  • Smerdel-Ramoya A, Finholt C, Lilleby V, Gilboe IM, Harbo HF, Maslinski S, et al. Systemic lupus erythematosus and the extended major histocompatibility complex—evidence for several predisposing loci. Rheumatology (Oxford) 2005; 44: 1368–1373
  • Nejentsev S, Howson JM, Walker NM, Szeszko J, Field SF, Stevens HE, et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 2007; 450: 887–892
  • Stojanovich L, Zandman-Goddard G, Pavlovich S, Sikanich N. Psychiatric manifestations in systemic lupus erythematosus. Autoimmun Rev 2007; 6: 421–426
  • Sundquist K, Li X, Hemminki K, Sundquist J. Subsequent risk of hospitalization for neuropsychiatric disorders in patients with rheumatic diseases: A nationwide study from Sweden. Arch Gen Psychiatry 2008; 65: 501–507
  • Valtýsdóttir ST, Gudbjörnsson B, Lindqvist U, Hällgren R, Hetta J. Anxiety and depression in patients with primary Sjögren's syndrome. J Reumatol 2000; 27: 165–169
  • Stevenson HA, Jones ME, Rostron JL, Longman LP, Field EA. UK patients with primary Sjögren's syndrome are at increased risk from clinical depression. Gerodontology 2004; 21: 141–145
  • Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: More than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 2004; 34: 501–537
  • Mahler M, Kessenbrock K, Szmyrka M, Takasaki Y, Garcia-De La Torre I, Shoenfeld Y, et al. International multicenter evaluation of autoantibodies to ribosomal P proteins. Clin Vaccine Immunol 2006; 13: 77–83
  • Bonfa E, Golombek SJ, Kaufman LD, Skelly S, Weissbach H, Brot N, et al. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 1987; 317: 265–271
  • Katzav A, Solodeev I, Brodsky O, Chapman J, Pick CG, Blank M, et al. Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum 2007; 56: 938–948
  • Zorzon M, de Masi R, Nasuelli D, Ukmar M, Mucelli RP, Cazzato G, et al. Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects. J Neurol 2001; 248: 416–421
  • Lee HS, Lee AT, Criswell LA, Seldin MF, Amos CI, Carulli JP, et al. Several regions in the major histocompatibility complex confer risk for anti-CCP-antibody positive rheumatoid arthritis, independent of the DRB1 locus. Mol Med 2008; 14: 293–300

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.